This website uses cookies to ensure you get the best experience. Learn more about DOAJ’s privacy policy.
Hide this message
Pediatric Neurology Briefs (Dec 2001)
Affiliations
Read online
The effectiveness and safety of divalproex sodium administered daily in migraine prophylaxis were evaluated in 23 children, ages 7 to 17 years (mean, 12.4 yrs), at Ohio State University College of Medicine, Children’s Hospital, Columbus, OH.